当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析

健帆生物

(300529)

  

流通市值:99.68亿  总市值:155.33亿
流通股本:5.12亿   总股本:7.99亿

健帆生物(300529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.21亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益369951.26万元,未分配利润264817.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产552123.17万元,负债182171.91万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入560,623,604.232,011,817,980.591,556,021,993.541,134,416,582.38
营业总成本307,800,952.251,338,531,874.321,020,308,100.76691,481,834.59
其他经营收益
营业利润261,216,188.99690,786,476.63586,380,633.08481,171,504.06
利润总额260,014,653.23660,127,097.16552,053,862.95461,903,988.17
净利润220,647,736.37531,671,178.89451,858,349.46388,668,556.92
每股收益
其他综合收益-2,799,145.61--
综合收益总额220,647,736.37534,470,324.5451,858,349.46388,668,556.92
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,034,437,075.22,917,973,577.812,915,854,287.42,634,307,821.89
非流动资产:
非流动资产合计2,486,794,577.612,490,980,424.152,620,246,316.852,632,959,589.59
资产总计5,521,231,652.815,408,954,001.965,536,100,604.255,267,267,411.48
流动负债:
流动负债合计348,560,141.09502,096,990.91685,205,805.61739,598,918.35
非流动负债:
非流动负债合计1,473,158,938.311,435,531,590.71,422,240,153.751,405,250,003
负债合计1,821,719,079.41,937,628,581.612,107,445,959.362,144,848,921.35
所有者权益(或股东权益):
归属于母公司股东权益合计3,699,769,529.763,471,717,243.943,429,268,141.053,122,714,168.66
股东权益合计3,699,512,573.413,471,325,420.353,428,654,644.893,122,418,490.13
负债和股东权益合计5,521,231,652.815,408,954,001.965,536,100,604.255,267,267,411.48
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计614,887,721.652,459,988,549.011,865,890,761.171,402,751,627.12
经营活动现金流出小计358,996,312.791,738,772,105.821,292,650,606864,470,191.73
经营活动产生的现金流量净额255,891,408.86721,216,443.19573,240,155.17538,281,435.39
投资活动产生的现金流量:
投资活动现金流入小计1,027,451,350.094,590,744,142.131,930,802,969.431,788,774,548.16
投资活动现金流出小计3,224,024,768.323,947,590,825.893,173,223,187.592,678,769,929.41
投资活动产生的现金流量净额-2,196,573,418.23643,153,316.24-1,242,420,218.16-889,995,381.25
筹资活动产生的现金流量:
筹资活动现金流入小计31,107,959.861,233,378,827.84528,230,606.273,948,636.48
筹资活动现金流出小计114,685,729.971,796,710,684.181,124,700,280.94701,421,484.34
筹资活动产生的现金流量净额-83,577,770.11-563,331,856.34-596,469,674.74-627,472,847.86
汇率变动对现金及现金等价物的影响-1,821,163.03-1,722,510.72-525,067.8593,947.11
现金及现金等价物净增加额-2,026,080,942.51799,315,392.37-1,266,174,805.58-979,092,846.61
期末现金及现金等价物余额448,900,691.112,474,981,633.62409,491,435.67696,573,394.64
补充资料:
现金及现金等价物的净增加额-799,315,392.37--979,092,846.61
最新报告期:2026-05-04
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
天风证券杨松0.820.911.042026-05-04
华泰证券代雯,高鹏,杨昌源0.810.900.992026-04-28
国金证券何冠洲,甘坛焕0.860.991.152026-04-28
TOP↑